Figures & data
Table 1 Patient demographics and clinical characteristics by GLP1 RA status (global)
Table 2 Patient demographics and clinical characteristics by region
Figure 1 Patient-survey cohort (n=2,173).
Abbreviations: GLP1 RA, glucagon-like peptide-1 receptor agonist; T2DM, type 2 diabetes mellitus.
![Figure 1 Patient-survey cohort (n=2,173).](/cms/asset/45dc59f1-23f8-4639-8d33-1dfa1d6dfd37/dmso_a_141235_f0001_c.jpg)
Figure 2 Reasons for GLP1 RA discontinuation in the past 6 months, ranked by frequency.
Abbreviations: GI, gastrointestinal; GLP1 RA, glucagon-like peptide-1 receptor agonist.
![Figure 2 Reasons for GLP1 RA discontinuation in the past 6 months, ranked by frequency.](/cms/asset/0dd78763-95f0-4d1b-98a1-819220255bc7/dmso_a_141235_f0002_c.jpg)
Figure 3 Problems reported with GLP1 RA treatment.
Abbreviations: GI, gastrointestinal; GLP1 RA, glucagon-like peptide-1 receptor agonist.
![Figure 3 Problems reported with GLP1 RA treatment.](/cms/asset/02179ede-56f1-4e7e-997d-f5965da445ef/dmso_a_141235_f0003_c.jpg)
![Figure 3 Problems reported with GLP1 RA treatment.](/cms/asset/5bcda536-9a1f-472e-89e0-b91d217ad51a/dmso_a_141235_f0003a_c.jpg)